8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2017 / Randomized controlled trial
Adults with metabolic syndrome were randomized to consume either freeze-dried blueberry smoothies or a placebo twice daily for six weeks. Blueberry supplementation reduced superoxide and total reactive oxygen species in monocytes and whole blood compared to placebo (p ≤ 0.05). It also raised myeloid dendritic cell counts, decreased monocyte expression of TNF-alpha, IL-6, and TLR4, and decreased circulating GMCSF levels (p ≤ 0.05).
Nair AR, Mariappan N, Stull AJ, et al. Food Funct, 2017. PMID 29019365
2017 / Randomized crossover trial
Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.
Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041
2010 / Randomized controlled trial
A double-blind, randomized, placebo-controlled study evaluated twice-daily smoothies with 22.5 g blueberry bioactives or placebo for 6 weeks in 32 obese, insulin-resistant adults. Mean insulin sensitivity improved more with blueberries (1.7 ± 0.5 mg·kg FFM⁻¹·min⁻¹) than with placebo (0.4 ± 0.4 mg·kg FFM⁻¹·min⁻¹, P = 0.04). Adiposity, energy intake, and inflammatory biomarkers did not change significantly.
Stull AJ, Cash KC, Johnson WD, et al. J Nutr, 2010. PMID 20724487